Antiprotozoal agents

Jun 09, 2020

Ceek and Lupin Sign a Marketing Agreement to Improve OB/GYN and Patient Exam Experience with the Nella® Products

Apr 22, 2020

Lupin Announces SOLOSEC® (secnidazole) Achievement of Preferred Status on Express Scripts National Preferred Formulary, One of the Largest Commercial Formularies in the U.S.

May 21, 2019

Cutaneous and Systemic Leishmaniasis Market Poised to Register 3.3% CAGR Through 2028 - Persistence Market Research

Mar 14, 2019

Bayer's Phase III Clinical Trial Of Nifurtimox In Pediatric Patients With Chagas Disease Meets Primary Endpoint

Feb 19, 2019

Antifungal Drugs Market Worth $17.72 Billion by 2023 at 3.7% CAGR, Says AMR

Aug 09, 2018

SCYNEXIS Reports Second Quarter 2018 Financial Results and Provides Company Update

Jun 18, 2018

The US FDA Approves First Supplemental Abbreviated New Drug Application (sANDA) for Glenmark Pharmaceuticals' Manufacturing Facility in Monroe, North Carolina

Mar 13, 2018

SCYNEXIS Reports Full Year 2017 Financial Results and Provides Company Update

Aug 31, 2017

U.S. FDA Approves Chemo Group's Benznidazole to Treat Children with Chagas Disease

Jun 28, 2017

FDA Grants Profounda Inc. Orphan Drug Designation for treatment of Granulomatous Amebic Encephalitis (GAE) with Miltefosine